$ Value
$0
Shares
75,000
Price
$0
Filed
Feb 13
Insider
Name
Gregoire Sylvie
Title
—
CIK
0001335822
Roles
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
75,000
Footnotes
Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the President & Chief Executive Officer of the Issuer and a member of its Board of Directors. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. | The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.
Filing Info
Gregoire Sylvie's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-17 | CRVO | ▲ | $91K |
| 2025-11-17 | CRVO | ▲ | $91K ★ |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-13 | CRVO | ▲ | $33K |
| 2025-11-12 | CRVO | ▲ | $41K |
| 2025-06-23 | CRVO | A | $0 |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |